Gene Therapy Co. Inks Better Ch. 11 Financing Deal
Sangamo Therapeutics on Wednesday told a Delaware bankruptcy judge it has negotiated new Chapter 11 financing that will provide the biotechnology company with more money at a lower interest rate and...To view the full article, register now.
Already a subscriber? Click here to view full article